Technology insight: Ablative techniques for Barrett's esophagus - Current and emerging trends

Nature Clinical Practice Gastroenterology and Hepatology

Volumn 2, Issue 7, 2005, Pages 323-330

  Johnson, Mark H ^a  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

Author keywords

Ablation; Barrett's esophagus; Dysplasia; Esophageal cancer

Indexed keywords

3 TETRA(HYDROXYPHENYL)CHLORIN; AMINOLEVULINIC ACID; BENZOPORPHYRIN DERIVATIVE; NITROGEN; OMEPRAZOLE; PHOSPHATE; PHOTOFRIN; PHOTOSENSITIZING AGENT; POTASSIUM; PROTON PUMP INHIBITOR; UNCLASSIFIED DRUG;

ARGON PLASMA COAGULATION; BARRETT ESOPHAGUS; BLEEDING; CANCER GRADING; CANCER MORTALITY; CANCER RISK; CANCER STAGING; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DISEASE COURSE; DOSE RESPONSE; DRUG MEGADOSE; ELECTROCOAGULATION; ENDOSCOPIC MUCOSAL RESECTION; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGUS CANCER; ESOPHAGUS PERFORATION; ESOPHAGUS RESECTION; ESOPHAGUS STRICTURE; ESOPHAGUS ULCER; FOLLOW UP; HISTOPATHOLOGY; HUMAN; INTERMETHOD COMPARISON; LOW LEVEL LASER THERAPY; MEDICAL TECHNOLOGY; MORBIDITY; NEODYMIUM LASER; PAIN; PHOTODYNAMIC THERAPY; PNEUMATOSIS INTESTINALIS; PNEUMOPERITONEUM; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; REVIEW; RISK ASSESSMENT; RISK REDUCTION; STATISTICAL SIGNIFICANCE; SUBCUTANEOUS EMPHYSEMA; SUNBURN; SURGICAL INJURY; ADENOCARCINOMA; CATHETER ABLATION; CLINICAL TRIAL (TOPIC); COMPLICATION; CRYOSURGERY; ESOPHAGEAL NEOPLASMS; GASTROESOPHAGEAL REFLUX; LASER COAGULATION; MUCOSA; PHOTOCHEMOTHERAPY; SURGERY;

BARRETT ESOPHAGUS; CATHETER ABLATION; COMBINED MODALITY THERAPY; CRYOSURGERY; ESOPHAGOSCOPY; HUMANS; LASER COAGULATION; PHOTOCHEMOTHERAPY; ADENOCARCINOMA; CLINICAL TRIALS AS TOPIC; ELECTROCOAGULATION; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; GASTROESOPHAGEAL REFLUX; LASER THERAPY; MUCOUS MEMBRANE;

EID: 23344443056     PISSN: 17434378     EISSN: None     Source Type: Journal    
DOI: 10.1038/ncpgasthep0214     Document Type: Review

References (48)

1. Brown LM and Devesa SS (2002) Esophageal and gastric cancer in the United States. Ann Epidemiol 12: 492-493
2. Devesa SS et al. (1998) Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 83: 2049-2053
3. Lagergren J et al. (1999) Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 340: 825-831
4. Falk GW (2002) Barrett's esophagus. Gastroenterology 122: 1569-1591
5. Gross CP et al. (2002) The Adoption of Ablation Therapy for Barrett's Esophagus: A Cohort Study of Gastroenterologists. Am J Gastro 97: 279-286
6. Haag S et al. (1999) Regression of Barrett's esophagus: the role of acid suppression, surgery and ablative methods. Gatrointest Endosc 50: 229-240
7. Brown SB et al. (2004) The present and future role of photodynamic therapy in cancer treatment. Lancet Oncol 5: 497-508
8. Tang S et al. (2004) Photodynamic therapy in the esophagus. Photodiagnosis and Photodynamic Therapy 1: 65-74
9. US Food and Drug Administration (2003) FDA approves Photofrin for treatment of pre-cancerous lesions in Barrett's esophagus [http://www.fda.gov/bbs/topics/ANSWERS/2003/ANS01246.html] (accessed 6 June 2005)
10. Overholt BF et al. (1999) Photodynamic therapy for Barrett's esophagus: follow-up in 100 patients. Gastrointest Endosc 49: 1-7
11. Rohini V et al. (2004) Cost-effectiveness of photodynamic therapy for high-grade dysplasia in Barrett's esophagus. Gastrointest Endosc 60: 739-756
12. Ban S et al. (2004) Histoplatholoci Aspects of Photodynamic Therapy for Dysplasia and Early Adenocarcinoma Arising in Barrett's Esophagus. Am J Surg Pathol 28: 1466-1473
13. Van den Bogert J et al. (1999) Endoscopic ablation for Barrett's esophagus with high grade dysplasia: a review. Am J Gastroenterol 94: 1153-1160
14. Gossner L et al. (1999) KTP laser destruction of dysplasia and early cancer in columnar-lined Barrett's esophagus. Gastrointest Endosc 49: 8-12
15. Biddlestone LR et al. (1998) The histopathology of treated Barrett's esophagus. Squamous reepithelialization after acid suppression and laser and photodynamic therapy. Am J Surg Pathol 22: 239-245
16. Salo JA et al. (1998) Treatment of Barrett's esophagus by endoscopic laser ablation and antireflux surgery. Ann Surg 227: 621-623
17. Bonavina L et al. (1999) Endoscopic laser ablation of nondysplastic Barrett's epithelium: is it worthwhile? J Gastrointest Surg 3: 194-199
18. Barham CP et al. (1997) Photothermal laser ablation of Barrett's oesophagus: endoscopic and histologic evidence of squamous re-epithelialisation. Gut 41: 281-284
19. Luman W et al. (1996) Failure of Nd - YAG photocoagulation therapy as treatment for Barrett's esophagus: a pilot study. Eur J Gastroenterol Hepatol 8: 627-630
20. Weston AP and Sharma P (2002) Neodymium:yttrium-aluminum garnet contact laser ablation of Barrett's high grade dysplasia and early adenocarcinoma. Am J Gastroenterol 97: 2998-3006
21. Eisen GM (2003) Ablation therapy in Barrett's esophagus. Gastrointest Endosc 58: 760-769
22. Michopoulos S et al. (1999) Complete regression of Barrett's esophagus with heat probe thermocoagulation: mid-term results. Gastrointest Endsoc 50: 165-172
23. Sampliner RE et al. (1996) Reversal of Barrett's esophagus with acid suppression and multipolar electrocoagulation: preliminary results. Gastrointest Endosc 44: 532-535
24. Kovacs BJ et al. (1999) Successful reversal of Barrett's esophagus with multipolar electrocoagulation despite inadequate acid suppression. Gastrointest Endosc 49: 547-553
25. Montes CG et al. (1999) Antireflux surgery followed by bipolar electrocoagulation in the treatment of Barrett's esophagus. Gastrointest Endosc 50: 173-177
26. Sharma P et al. (1997) Normalization of esophageal pH with high-dose proton pump inhibitor theray does not result in regression of Barrett's esophagus. Am J Gastroenterol 92: 582-585
27. Ackroyed R (1999) Ablation treatment for Barrett's oesophagus: what depth of tissue destruction is needed? J Clin Pathol 52: 509-512
28. Sampliner RE (2004) Endoscopic ablative therapy for Barrett's esophagus: current status. Gastrointest Endosc 59: 66-69
29. Kahaleh M et al. (2002) Long-term follow-up and factors predictive of recurrence in Barrett's esophagus treated by argon plasma coagulation and acid suppression. Endoscopy 34: 950-955
30. Schulz H et al. (2000) Ablation of Barrett's epithelium by endoscopic argon plasma coagulation in combination with high-dose omeprazole. Gastrointest Endosc 51: 659-663
31. Madisch A et al. (2005) Long-term follow-up after complete ablation of Barrett's esophagus with argon plasma coagulation. World J Gastroenterol 11: 1182-1186
32. Byrne JP et al. (1998) Restoration of the normal squamous lining in Barrett's esophagus by argon beam plasma coagulation. Am J Gastroenterol 93: 1810-1815
33. Soetikno RM et al. (2003) Endoscopic mucosal resection. Gastrointest Endosc 57: 567-579
34. Ell C et al. (2000) Endoscopic mucosal resection of early cancer and high-grade dysplasia in Barrett's esophagus. Gastroenterology 118: 670-677
35. Seewald S et al. (2003) Circumferential EMR and complete removal of Barrett's epithelium: A new approach to management of Barrett's esophagus containing high-grade intraepithelial neoplasia and intramucosal carcinoma. Gastrointest Endosc 57: 854-859
36. Ganz RA et al. (2004) Complete ablation of esophageal epithelium with a balloon-based bipolar electrode: a phased evaluation in the porcine and in the human esophagus. Gastrointest Endosc 60: 1002-1010
37. Sharma VK et al. (2004) A Randomized Multi-Center Trial of Radiofrequency (RF) Ablation of Specialized Intestinal Metaplasia (SIM) of the Esophagus Using a Balloon-based Bipolar Electrode Array: Preliminary Results [abstract]. Gastroentest Endosc 59: a718
38. Grana L et al. (1981) Freezing of the esophagus: histologic changes and immunologic response. Int Surg 66: 295-301
39. Dvorakova K et al. (2005) Apoptosis Resistance in Barrett's Esophagus: Ex vivo Bioassy of Live Stressed Tissue. Am J Gastroenterol 100: 424-431
40. Johnston MH et al.: Cryoablation of Barrett's esophagus (BE): A pilot study. Gastrointestinal Endosc, in press
41. Peters FP et al. (2005) Endoscopic treatment of high-grade dysplasia and early stage cancer in Barrett's esophagus. Gastrointest Endosc 61: 506-514
42. Dulai GS et al. (2005) Randomized trial of argon plasma coagulation vs. multipolar electrocoagulation for ablation of Barrett's esophagus. Gastrointest Endosc 61: 232-240
43. Kelty CJ et al. (2004) Endoscopic Ablation of Barrett's Oesophagus: A Randomized-Controlled Trial of Photodynamic Therapy vs. Argon Plasma Coagulation. Aliment Pharmacol Ther 20: 1289-1296
44. Faigel DO (2002) Effect of multipolar electrocoagulation on EUS findings in Barrett's esophagus. Gastrointest Endosc 55: 23-26
45. Sampliner RE (1997) Ablative therapies for the columnar-lined esophagus. Gastroenterol Clin North Am 26: 685-694
46. Johnston MH (2003) Cryotherapy and other new techniques. Gastrointest Endoscopy Clin N Am 13: 491-504
47. Van Laethem JL et al. (2001) Argon plasma coagulation in the treatment of Barrett's high-grade dysplasia and in situ adenocarcinoma. Endoscopy 33: 257-261
48. Van Laethem JL et al. (2000) Intramucosal adenocarcinoma arising under squamous reepithelialization of Barrett's esophagus. Gut 46: 574-547